Beam Therapeutics (BEAM) Stock Drops 4% on Clinical Hold News

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Beam Therapeutics (BEAM) stock is slipping on Monday after the U.S. Food and Drug Administration placed a clinical hold on one of its drugs.

The post Beam Therapeutics (BEAM) Stock Drops 4% on Clinical Hold News appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• Cash Holders Could Get Hit Hard THIS FRIDAY